| Literature DB >> 26503585 |
Lars Gabrys1, Susanne Jordan2, Martin Schlaud3.
Abstract
BACKGROUND: For patients, usually the first and most preferred contact person on health issues is still the doctor and most persons see their doctor at least once a year. Therefore, physical activity counselling strategies delivered by a physician seem to be a promising approach for physical activity improvement. The aim of this work is to show prevalence and time trends in physical activity counselling by primary health care physicians from 1997-1999 to 2008-2011 in Germany.Entities:
Mesh:
Year: 2015 PMID: 26503585 PMCID: PMC4624583 DOI: 10.1186/s12966-015-0299-9
Source DB: PubMed Journal: Int J Behav Nutr Phys Act ISSN: 1479-5868 Impact factor: 6.457
Absolute numbers of men and women in GNHIES 98 and DEGS 1
| GNHIES 98 (1997–1999) | DEGS 1 (2008–2011) | |||
|---|---|---|---|---|
| Age [years] | Men | Women | Men | Women |
| 18–29 | 626 | 636 | 525 | 547 |
| 30–39 | 731 | 785 | 473 | 541 |
| 40–49 | 606 | 671 | 716 | 823 |
| 50–59 | 645 | 677 | 735 | 857 |
| 60–64 | 283 | 309 | 340 | 381 |
| Total | 2891 | 3078 | 2789 | 3149 |
Fig. 1Age stratified prevalence estimates of physicians’ counselling on patients’ physical activity behaviour. Detailed legend: Prevalence estimates incl. 95 % confidence intervals are shown for the time periods of both health surveys; 1997–1999 (GNHIES 98) and 2008–2011 (DEGS 1)
Temporal trends in prevalence of physical activity counselling and effect estimates of stratified group comparisons
| Physical activity counselling prevalence | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1997–1999 | 2008–2011 | 1997–1999 vs 2008–2011 | |||||||
| (%) | OR (95 % CI) | (%) | OR (95 % CI) | OR (95 % CI) | |||||
| Men | 11.1 | Ref. | 9.4 | Ref. | 0.84 (0.62–1.03) | ||||
| Women | 9.3 | 0.82 (0.67–1.02) | 7.7 | 0.80 (0.63–1.02) | 0.82 (0.65–1.02) | ||||
| Men | Women | Men | Women | Total | |||||
| (%) | OR (95 % CI) | (%) | OR (95 % CI) | (%) | OR (95 % CI) | (%) | OR (95 % CI) | OR (95 % CI) | |
| BMI | |||||||||
| 18.5 – <25.0 | 9.8 | Ref. | 9.4 | Ref. | 6.5 | Ref. | 6.2 | Ref. | 0.64*** (0.53–0.77) |
| 25.0 – <30.0 | 11.4 | 1.19 (0.86–1.63) | 10.2 | 1.10 (0.81–1.49) | 8.8 | 1.39 (0.94–2.08) | 6.5 | 1.06 (0.73–1.53) | 0.70** (0.54–0.91) |
| 30.0 + | 12.2 | 1.29 (0.84–1.96) | 7.8 | 0.82 (0.54–1.25) | 15.1 | 2.56*** (1.67–3.93) | 9.7 | 1.62* (1.08–2.42) | 1.30 (0.92–1.82) |
| Diabetes | |||||||||
| No | 11.1 | Ref. | 9.2 | Ref. | 8.6 | Ref. | 7.1 | Ref. | 0.76*** (0.65–0.88) |
| Yes | 10.8 | 0.97 (0.46–2.03) | 9.8 | 1.08 (0.39–2.99) | 29.8 | 4.51*** (2.54–8.01) | 26.4 | 4.67*** (2.65–8.25) | 3.42*** (1.68–6.96) |
| Coronary heart disease | |||||||||
| No | 10.8 | Ref. | 9.2 | Ref. | 10.9 | Ref. | 8.5 | Ref. | 0.97 (0.80–1.17) |
| Yes | 17.7 | 1.77 (0.95–3.29) | 9.2 | 1.01 (0.40–2.53) | 24.0 | 2.56*** (1.54–4.27) | 7.6 | 0.89 (0.24–3.26) | 1.36 (0.68–2.72) |
| Hypertension | |||||||||
| No | 10.6 | Ref. | 9.3 | Ref. | 8.1 | Ref. | 6.9 | Ref. | 0.73*** (0.62–0.86) |
| Yes | 14.1 | 1.39 (0.93–2.07) | 8.4 | 0.89 (0.58–1.36) | 16.8 | 2.29*** (1.64–3.21) | 12.3 | 1.90** (1.30–2.79) | 1.36 (0.97–1.90) |
| Cancer | |||||||||
| No | 11.1 | Ref. | 9.1 | Ref. | 9.3 | Ref. | 7.6 | Ref. | 0.82* (0.71–0.96) |
| Yes | 9.0 | 0.79 (0.24–2.58) | 10.2 | 1.13 (0.45–2.83) | 14.0 | 1.59 (0.74–3.39) | 8.2 | 1.08 (0.54–2.19) | 1.05 (0.44–2.51) |
| Socio economic status (SES) | |||||||||
| Low | 9.0 | Ref. | 7.7 | Ref. | 5.9 | Ref. | 6.4 | Ref. | 0.72 (0.47–1.11) |
| middle | 9.8 | 1.10 (0.70–1.72) | 8.1 | 1.06 (0.70–1.62) | 9.4 | 1.67 (0.93–2.98) | 7.9 | 1.25 (0.75–2.08) | 0.96 (0.79–1.18) |
| High | 15.6 | 1.86* (1.15–2.99) | 14.4 | 2.03** (1.23–3.35) | 12.0 | 2.18** (1.21–3.95) | 8.1 | 1.28 (0.70–2.33) | 0.64** (0.47–0.87) |
| Sports activity | |||||||||
| No sports | 7.7 | Ref. | 5.4 | Ref. | 7.5 | Ref. | 7.2 | Ref. | 1.15 (0.85–1.55) |
| <1 h/week | 13.1 | 1.82* (1.14–2.89) | 11.4 | 2.28*** (1.45–3.60) | 10.7 | 1.49 (0.94–2.55) | 6.4 | 0.89 (0.55–1.45) | 0.67* (0.47–0.95) |
| 1–2 h/week | 13.8 | 1.93** (1.29–2.88) | 11.2 | 2.23*** (1.45–3.41) | 11.1 | 1.55 (0.94–2.55) | 10.3 | 1.47* (1.03–2.12) | 0.85 (0.62–1.17) |
| 2–4 h/week | 9.7 | 1.29 (0.83–2.00) | 14.8 | 3.06*** (2.02–4.65) | 10.3 | 1.42 (0.83–2.42) | 6.5 | 0.89 (0.56–1.41) | 0.67* (0.48–0.94) |
| > 4 h/week | 17.8 | 2.61*** (1.75–3.90) | 17.1 | 3.65*** (1.99–6.68) | 8.1 | 1.09 (0.63–1.88) | 6.1 | 0.84 (0.46–1.51) | 0.38*** (0.25–0.58) |
| Cardio-metabolic risk (score) | |||||||||
| normal risk (0–1) | 10.5 | Ref. | 9.3 | Ref. | 7.8 | Ref. | 7.0 | Ref. | 0.73*** (0.62–0.85) |
| elevated risk (2) | 15.8 | 1.60* (1.07–2.40) | 9.1 | 0.98 (0.60–1.58) | 18.0 | 2.60*** (1.84–3.67) | 11.4 | 1.72* (1.08–2.74) | 1.22 (0.83–1.79) |
| high risk (3) | 5.1 | 0.46 (0.13–1.65) | 11.1 | 1.22 (0.39–3.85) | 31.2 | 5.37*** (2.42–11.89) | 33.1 | 6.62*** (2.76–15.84) | 5.33*** (1.89–15.00) |
*p < 0.05; **p < 0.01; ***p < 0.001
Temporal trends in prevalence of participation in physical activity programmes in accordance to physical activity counselling and effect estimates of group comparisons
| 1997–1999 | 2008–2011 | 1997–1999 vs. 2008–2011 | |||||
|---|---|---|---|---|---|---|---|
| Counselling | No counselling | OR (95 % CI) | Counselling | No counselling | OR (95 % CI) | OR (95 % CI) | |
| Men | 10.0 | 5.3 | 2.00** (1.22–3.30) | 18.6 | 7.5 | 2.82*** (1.85–4.27) | 1.57*** (1.21–2.06) |
| Women | 20.8 | 9.5 | 2.50*** (1.65–3.78) | 31.7 | 17.5 | 2.20*** (1.58–3.05) | 2.02*** (1.68–2.44) |
| OR (95 % CI) | 2.40** (1.29–4.33) | 1.89*** (1.47–2.44) | 2.04** (1.30–3.18) | 2.61*** (2.11–4.21) | |||
*p < 0.05; **p < 0.01; ***p < 0.001